The ENPP1 Q121 variant predicts major cardiovascular events in high-risk individuals: Evidence for interaction with obesity in diabetic patients

Diabetes

Volumn 60, Issue 3, 2011, Pages 1000-1007

  Bacci, Simonetta ^a   Rizza, Stefano ^b   Prudente, Sabrina ^a   Spoto, Belinda ^c   Powers, Christine ^d   Facciorusso, Antonio ^a   Pacilli, Antonio ^a   Lauro, Davide ^b   Testa, Alessandra ^c   Zhang, Yuan Yuan ^d,e   Di Stolfo, Giuseppe ^a   Mallamaci, Francesca ^c   Tripepi, Giovanni ^c   Xu, Rui ^d,e   Mangiacotti, Davide ^a   Aucella, Filippo ^a   Lauro, Renato ^b   Gervino, Ernest V ^e,f   Hauser, Thomas H ^e,f   Copetti, Massimiliano ^a   De Cosmo, Salvatore ^a   Pellegrini, Fabio ^a,g   Zoccali, Carmine ^c   Federici, Massimo ^b   Doria, Alessandro ^d,e   Trischitta, Vincenzo ^a,h   more..

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c CNR Consiglio Nazionale delle Ricerche   (Italy)

^d JOSLIN DIABETES CENTER   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^g Consorzio Mario Negri Sud ^*  (Italy)

^h SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; DEATH; DIABETES MELLITUS; DIABETIC PATIENT; DIALYSIS; FEMALE; GENETIC POLYMORPHISM; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; STROKE;

AGED; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; INCIDENCE; ITALY; MALE; MIDDLE AGED; OBESITY; PHOSPHORIC DIESTER HYDROLASES; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; PYROPHOSPHATASES; RISK FACTORS; STATISTICS, NONPARAMETRIC;

EID: 79952392468     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db10-1300     Document Type: Article

References (51)

1. Lloyd-Jones D, Adams RJ, Brown TM, et al.; Writing Group Members; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2010 update: a report from the American Heart Association. Circulation 2010;121:e46-e215
2. Smyth S, Heron A. Diabetes and obesity: the twin epidemics. Nat Med 2006;12:75-80 (Pubitemid 43050080)
3. Goya Wannamethee S, Gerald Shaper A, Whincup PH, Walker M. Overweight and obesity and the burden of disease and disability in elderly men. Int J Obes Relat Metab Disord 2004;28:1374-1382 (Pubitemid 39481840)
4. Wang Y, Beydoun MA, Liang L, Caballero B, Kumanyika SK. Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic. Obesity (Silver Spring) 2008;16:2323-2330
5. Hamsten A, Eriksson P. Identifying the susceptibility genes for coronary artery disease: from hyperbole through doubt to cautious optimism. J Intern Med 2008;263:538-552 (Pubitemid 351533558)
6. McPherson R, Pertsemlidis A, Kavaslar N, et al. A common allele on chromosome 9 associated with coronary heart disease. Science 2007;316: 1488-1491 (Pubitemid 46906617)
7. Helgadottir A, Thorleifsson G, Manolescu A, et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 2007; 316:1491-1493 (Pubitemid 46906618)
8. Samani NJ, Erdmann J, Hall AS, et al.; WTCCC and the Cardiogenics Consortium. Genomewide association analysis of coronary artery disease. N Engl J Med 2007;357:443-453 (Pubitemid 47204873)
9. Erdmann J, Grosshennig A, Braund PS, et al.; Italian Atherosclerosis, Thrombosis, and Vascular Biology Working Group; Myocardial Infarction Genetics Consortium; Wellcome Trust Case Control Consortium; Cardiogenics Consortium. New susceptibility locus for coronary artery disease on chromosome 3q22.3. Nat Genet 2009;41:280-282
10. Myocardial Infarction Genetics Consortium, Kathiresan S, Voight BF, Purcell S, et al. Genome-wide association of early-onset myocardial infarction with common single polymorphisms, common copy number variants, and rare copy number variants. Nat Genet 2009;41:334-341
11. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607
12. Howard G, O'Leary DH, Zaccaro D, et al.; The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Insulin sensitivity and atherosclerosis. Circulation 1996;93:1809-1817
13. Hedblad B, Nilsson P, Engström G, Berglund G, Janzon L. Insulin resistance in non-diabetic subjects is associated with increased incidence of myocardial infarction and death. Diabet Med 2002;19:470-475 (Pubitemid 34639157)
14. Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB Sr, Wilson PW. Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study. Diabetes 2005;54:3252-3257 (Pubitemid 43334382)
15. Chen J, Muntner P, Hamm LL, et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 2004;140:167-174
16. De Cosmo S, Trevisan R, Minenna A, et al. Insulin resistance and the cluster of abnormalities related to the metabolic syndrome are associated with reduced glomerular filtration rate in patients with type 2 diabetes. Diabetes Care 2006;29:432-434 (Pubitemid 44106535)
17. Muniyappa R, Montagnani M, Koh KK, Quon MJ. Cardiovascular actions of insulin. Endocr Rev 2007;28:463-491 (Pubitemid 47236334)
18. Pedersen O. Genetics of insulin resistance. Exp Clin Endocrinol Diabetes 1999;107:113-118 (Pubitemid 29179277)
19. Rich SS, Bowden DW, Haffner SM, et al.; Insulin Resistance Atherosclerosis Study Family Study. Identification of quantitative trait loci for glucose homeostasis: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study. Diabetes 2004;53:1866-1875
20. Poulsen P, Levin K, Petersen I, Christensen K, Beck-Nielsen H, Vaag A. Heritability of insulin secretion, peripheral and hepatic insulin action, and intracellular glucose partitioning in young and old Danish twins. Diabetes 2005;54:275-283 (Pubitemid 40105123)
21. Goldfine ID, Maddux BA, Youngren JF, et al. The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities. Endocr Rev 2008;29:62-75 (Pubitemid 351252747)
22. Pizzuti A, Frittitta L, Argiolas A, et al. A polymorphism (K121Q) of the human glycoprotein PC-1 gene coding region is strongly associated with insulin resistance. Diabetes 1999;48:1881-1884 (Pubitemid 29415213)
23. Costanzo BV, Trischitta V, Di Paola R, et al. The Q allele variant (GLN121) of membrane glycoprotein PC-1 interacts with the insulin receptor and inhibits insulin signaling more effectively than the common K allele variant (LYS121). Diabetes 2001;50:831-836
24. Bacci S, Di Paola R, Menzaghi C, et al. ENPP1 Q121 variant, increased pulse pressure and reduced insulin signaling, and nitric oxide synthase activity in endothelial cells. Arterioscler Thromb Vasc Biol 2009;29:1678-1683
25. Abate N, Chandalia M, Satija P, et al. ENPP1/PC-1 K121Q polymorphism and genetic susceptibility to type 2 diabetes. Diabetes 2005;54:1207-1213 (Pubitemid 40446338)
26. Stolerman ES, Manning AK, McAteer JB, et al. Haplotype structure of the ENPP1 Gene and Nominal Association of the K121Q missense single nucleotide polymorphism with glycemic traits in the Framingham Heart Study. Diabetes 2008;57:1971-1977
27. Baratta R, Rossetti P, Prudente S, et al. Role of the ENPP1 K121Q polymorphism in glucose homeostasis. Diabetes 2008;57:3360-3364
28. Grarup N, Urhammer SA, Ek J, et al. Studies of the relationship between the ENPP1 K121Q polymorphism and type 2 diabetes, insulin resistance and obesity in 7,333 Danish white subjects. Diabetologia 2006;49:2097-2104 (Pubitemid 44168477)
29. Endler G, Mannhalter C, Sunder-Plassmann H, et al. The K121Q polymorphism in the plasma cell membrane glycoprotein 1 gene predisposes to early myocardial infarction. J Mol Med 2002;80:791-795 (Pubitemid 35478127)
30. Bacci S, Ludovico O, Prudente S, et al. The K121Q polymorphism of the ENPP1/PC-1 gene is associated with insulin resistance/atherogenic phenotypes, including earlier onset of type 2 diabetes and myocardial infarction. Diabetes 2005;54:3021-3025 (Pubitemid 41401102)
31. Moehlecke M, Kramer CK, Leitão CB, et al. [ENPP1 K121Q polymorphism and ischemic heart disease in diabetic patients]. Arq Bras Cardiol 2010;94: 157-161, 168-173, 159-163
32. Chen MP, Chung FM, Chang DM, et al. ENPP1 K121Q polymorphism is not related to type 2 diabetes mellitus, features of metabolic syndrome, and diabetic cardiovascular complications in a Chinese population. Rev Diabet Stud 2006;3:21-30
33. De Cosmo S, Minenna A, Zhang YY, et al. Association of the Q121 variant of ENPP1 gene with decreased kidney function among patients with type 2 diabetes. Am J Kidney Dis 2009;53:273-280
34. Testa A, Spoto B, Tripepi G, et al. The GLU298ASP variant of nitric oxide synthase interacts with asymmetric dimethyl arginine in determining cardiovascular mortality in patients with end-stage renal disease. J Hypertens 2005;23:1825-1830 (Pubitemid 41830422)
35. Panzetta G, Basile C, Santoro A, et al. Diabetics on dialysis in Italy: a nationwide epidemiological study. Nephrol Dial Transplant 2008;23:3988-3995
36. Prudente S, Hribal ML, Flex E, et al. The functional Q84R polymorphism of mammalian Tribbles homolog TRB3 is associated with insulin resistance and related cardiovascular risk in Caucasians from Italy. Diabetes 2005;54: 2807-2811 (Pubitemid 41233606)
37. Doria A, Wojcik J, Xu R, et al. Interaction between poor glycemic control and 9p21 locus on risk of coronary artery disease in type 2 diabetes. JAMA 2008;300:2389-2397
38. Olkin I, Sampson A. Comparison of meta-analysis versus analysis of variance of individual patient data. Biometrics 1998;54:317-322 (Pubitemid 28158806)
39. Pencina MJ, D'Agostino RB. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med 2004;23:2109-2123 (Pubitemid 38968032)
40. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008;27:157-172; discussion 207-212
41. Kang X, Shaw LJ, Hayes SW, et al. Impact of body mass index on cardiac mortality in patients with known or suspected coronary artery disease undergoing myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 2006;47:1418-1426
42. Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 2003;63:793-808 (Pubitemid 36315558)
43. Kalantar-Zadeh K, Block G, Horwich T, Fonarow GC. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol 2004;43:1439-1444 (Pubitemid 38496352)
44. Stevens J, Cai J, Pamuk ER, Williamson DF, Thun MJ, Wood JL. The effect of age on the association between body-mass index and mortality. N Engl J Med 1998;338:1-7 (Pubitemid 28040168)
45. Meyre D, Bouatia-Naji N, Tounian A, et al. Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes. Nat Genet 2005;37:863-867 (Pubitemid 41077112)
46. McAteer JB, Prudente S, Bacci S, et al.; ENPP1 Consortium. The ENPP1 K121Q polymorphism is associated with type 2 diabetes in European populations: evidence from an updated meta-analysis in 42,042 subjects. Diabetes 2008;57:1125-1130
47. Prudente S, Morini E, Trischitta V. Insulin signaling regulating genes: effect on T2DM and cardiovascular risk. Nat Rev Endocrinol 2009;5:682-693
48. Bochenski J, Placha G, Wanic K, et al. New polymorphism of ENPP1 (PC-1) is associated with increased risk of type 2 diabetes among obese individuals. Diabetes 2006;55:2626-2630 (Pubitemid 44871165)
49. Cauchi S, Nead KT, Choquet H, et al. The genetic susceptibility to type 2 diabetes may be modulated by obesity status: implications for association studies. BMC Med Genet 2008;9:45
50. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004;109(Suppl. 1):III27-III32
51. Abate N, Chandalia M, Di Paola R, Foster DW, Grundy SM, Trischitta V. Mechanisms of disease: Ectonucleotide pyrophosphatase phosphodiesterase 1 as a 'gatekeeper' of insulin receptors. Nat Clin Pract Endocrinol Metab 2006;2:694-701